Read More 1 minute read Hiring News News Luxa Biotechnology Appoints Dr. Keith Dionne as CEO to Lead Advanced RPESC Therapy Development Key Highlights Dr. Keith Dionne appointed as CEO of Luxa Biotechnology. Luxa develops a novel RPESC therapy for… byChris-Anne RoqueOctober 4, 2024